Skip to main content
. Author manuscript; available in PMC: 2024 Nov 7.
Published in final edited form as: Breast Cancer Res Treat. 2023 Oct 31;203(3):553–564. doi: 10.1007/s10549-023-07148-y

Table 2.

Results of multivariable models assessing the association between race/ethnicity and (a) time to surgical treatment (less than 1 month, less than 2 months, or less than 3 months from diagnosis), (b) type of surgery (BCS vs mastectomy)

Time to surgerya Treatment typeb
≤ 1 month ≤ 2 months ≤ 3 months BCS vs mastectomy
Model° N OR 95% CI OR 95% CI OR 95% CI N OR 95% CI
Model 1: Unadjusted 2069 2069 2069
 Non-hispanic Black 0.88 0.64 1.22 1.03 0.65 1.62 0.90 0.65 0.90 0.65 1.25
 Hispanic 0.68 * 0.49 0.94 0.58 ** 0.39 0.84 0.95 0.69 0.95 0.69 1.32
Model 2: Adjusted for demographics 2069 2069 2069
 Non-hispanic Black 0.79 0.56 1.11 0.92 0.57 1.48 0.93 0.66 0.93 0.66 1.31
 Hispanic 0.75 0.53 1.04 0.66* 0.44 0.99 0.95 0.68 0.95 0.68 1.33
Model 3: Adjusted for demographics and clinical characteristics 2069 2069 2069
 Non-hispanic Black 0.78 0.56 1.10 0.93 0.58 1.50 1.02 0.71 1.02 0.71 1.48
 Hispanic 0.74 0.53 1.04 0.67 * 0.45 0.99 1.01 0.72 1.01 0.72 1.45
°

Reference category is non-hispanic Whites

a

Models were adjusted for: age, marital status, SEER geographic region, self-reported comorbidities, tumor stage, type of surgery, medicare plan, survey administration mode, survey year, and time since survey

b

Modeling odds of breast conserving surgery(BCS) vs mastectomy adjusted for: age, marital status, SEER geographic region, self-reported comorbidities, tumor stage, medicare plan, survey administration mode, survey year, and time since survey Bold represents significant at

*

p < 0.05,

**

p < 0.01, ***p < 0.001